Riber: well oriented, new growth forecast for 2024
The group, world leader in molecular beam epitaxy (MBE) equipment, reported sales of 39.2 million euros last year, up 41% on FY 2022.
In the fourth quarter alone, sales growth was sustained at 48%, with sales reaching 23 million euros.
At December 31, the company's total order book stood at 26.3 million euros, down 12% on the previous year.
At around 12:30 p.m., the share price was up by around 1% in the wake of this publication.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction